Page last updated: 2024-11-12

(z,z)-babch

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID10361934
CHEMBL ID55035
SCHEMBL ID7444271
MeSH IDM0295469

Synonyms (7)

Synonym
1V2N
bdbm17277
4-{[(1z,3z)-3-[(4-carbamimidoylphenyl)methylidene]-2-oxocycloheptylidene]methyl}benzene-1-carboximidamide
(z,z)babch
chembl55035 ,
SCHEMBL7444271
4-[(z)-[(3z)-3-[(4-carbamimidoylphenyl)methylidene]-2-oxocycloheptylidene]methyl]benzenecarboximidamide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (17)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain T, TrypsinBos taurus (cattle)Ki1.25001.2500227.3214566.0000AID977610
Chain T, TrypsinBos taurus (cattle)Ki1.25001.2500227.3214566.0000AID977610
Chain T, TrypsinBos taurus (cattle)Ki1.25001.2500227.3214566.0000AID977610
Chain T, TrypsinBos taurus (cattle)Ki1.25001.2500227.3214566.0000AID977610
Chain T, TrypsinBos taurus (cattle)Ki1.25001.2500227.3214566.0000AID977610
Chain T, TrypsinBos taurus (cattle)Ki1.25001.2500227.3214566.0000AID977610
Chain T, TrypsinBos taurus (cattle)Ki1.25001.2500227.3214566.0000AID977610
Chain T, TrypsinBos taurus (cattle)Ki1.25001.2500227.3214566.0000AID977610
Chain T, TrypsinBos taurus (cattle)Ki1.25001.2500227.3214566.0000AID977610
Chain T, TrypsinBos taurus (cattle)Ki1.25001.2500227.3214566.0000AID977610
Chain T, TrypsinBos taurus (cattle)Ki1.25001.2500227.3214566.0000AID977610
Chain T, TrypsinBos taurus (cattle)Ki1.25001.2500227.3214566.0000AID977610
Chain T, TrypsinBos taurus (cattle)Ki1.25001.2500227.3214566.0000AID977610
Chain T, TrypsinBos taurus (cattle)Ki1.25001.2500227.3214566.0000AID977610
ProthrombinHomo sapiens (human)Ki0.50500.00000.78469.0000AID211009; AID211036; AID211045; AID211218
Coagulation factor XHomo sapiens (human)Ki0.00620.00000.47089.0000AID1797608; AID51652; AID51657; AID51669; AID51676; AID51847; AID52158
Cationic trypsinBos taurus (cattle)Ki0.02710.00001.07539.0000AID1797608; AID215060; AID215191; AID215209; AID7226
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (36)

Processvia Protein(s)Taxonomy
positive regulation of protein phosphorylationProthrombinHomo sapiens (human)
proteolysisProthrombinHomo sapiens (human)
acute-phase responseProthrombinHomo sapiens (human)
cell surface receptor signaling pathwayProthrombinHomo sapiens (human)
G protein-coupled receptor signaling pathwayProthrombinHomo sapiens (human)
blood coagulationProthrombinHomo sapiens (human)
positive regulation of cell population proliferationProthrombinHomo sapiens (human)
regulation of cell shapeProthrombinHomo sapiens (human)
response to woundingProthrombinHomo sapiens (human)
negative regulation of platelet activationProthrombinHomo sapiens (human)
platelet activationProthrombinHomo sapiens (human)
regulation of blood coagulationProthrombinHomo sapiens (human)
positive regulation of blood coagulationProthrombinHomo sapiens (human)
positive regulation of cell growthProthrombinHomo sapiens (human)
positive regulation of insulin secretionProthrombinHomo sapiens (human)
positive regulation of collagen biosynthetic processProthrombinHomo sapiens (human)
fibrinolysisProthrombinHomo sapiens (human)
negative regulation of proteolysisProthrombinHomo sapiens (human)
positive regulation of receptor signaling pathway via JAK-STATProthrombinHomo sapiens (human)
negative regulation of astrocyte differentiationProthrombinHomo sapiens (human)
positive regulation of release of sequestered calcium ion into cytosolProthrombinHomo sapiens (human)
regulation of cytosolic calcium ion concentrationProthrombinHomo sapiens (human)
cytolysis by host of symbiont cellsProthrombinHomo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionProthrombinHomo sapiens (human)
negative regulation of fibrinolysisProthrombinHomo sapiens (human)
antimicrobial humoral immune response mediated by antimicrobial peptideProthrombinHomo sapiens (human)
neutrophil-mediated killing of gram-negative bacteriumProthrombinHomo sapiens (human)
positive regulation of lipid kinase activityProthrombinHomo sapiens (human)
negative regulation of cytokine production involved in inflammatory responseProthrombinHomo sapiens (human)
positive regulation of protein localization to nucleusProthrombinHomo sapiens (human)
positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathwayProthrombinHomo sapiens (human)
ligand-gated ion channel signaling pathwayProthrombinHomo sapiens (human)
positive regulation of reactive oxygen species metabolic processProthrombinHomo sapiens (human)
proteolysisCoagulation factor XHomo sapiens (human)
blood coagulationCoagulation factor XHomo sapiens (human)
positive regulation of cell migrationCoagulation factor XHomo sapiens (human)
positive regulation of TOR signalingCoagulation factor XHomo sapiens (human)
proteolysisCationic trypsinBos taurus (cattle)
digestionCationic trypsinBos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (12)

Processvia Protein(s)Taxonomy
lipopolysaccharide bindingProthrombinHomo sapiens (human)
serine-type endopeptidase activityProthrombinHomo sapiens (human)
signaling receptor bindingProthrombinHomo sapiens (human)
calcium ion bindingProthrombinHomo sapiens (human)
protein bindingProthrombinHomo sapiens (human)
growth factor activityProthrombinHomo sapiens (human)
heparin bindingProthrombinHomo sapiens (human)
thrombospondin receptor activityProthrombinHomo sapiens (human)
serine-type endopeptidase activityCoagulation factor XHomo sapiens (human)
calcium ion bindingCoagulation factor XHomo sapiens (human)
protein bindingCoagulation factor XHomo sapiens (human)
phospholipid bindingCoagulation factor XHomo sapiens (human)
endopeptidase activityCationic trypsinBos taurus (cattle)
serine-type endopeptidase activityCationic trypsinBos taurus (cattle)
protein bindingCationic trypsinBos taurus (cattle)
metal ion bindingCationic trypsinBos taurus (cattle)
serpin family protein bindingCationic trypsinBos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (10)

Processvia Protein(s)Taxonomy
external side of plasma membraneProthrombinHomo sapiens (human)
collagen-containing extracellular matrixProthrombinHomo sapiens (human)
extracellular regionProthrombinHomo sapiens (human)
extracellular spaceProthrombinHomo sapiens (human)
endoplasmic reticulum lumenProthrombinHomo sapiens (human)
Golgi lumenProthrombinHomo sapiens (human)
plasma membraneProthrombinHomo sapiens (human)
extracellular exosomeProthrombinHomo sapiens (human)
blood microparticleProthrombinHomo sapiens (human)
collagen-containing extracellular matrixProthrombinHomo sapiens (human)
extracellular spaceProthrombinHomo sapiens (human)
extracellular regionCoagulation factor XHomo sapiens (human)
endoplasmic reticulum lumenCoagulation factor XHomo sapiens (human)
Golgi lumenCoagulation factor XHomo sapiens (human)
plasma membraneCoagulation factor XHomo sapiens (human)
external side of plasma membraneCoagulation factor XHomo sapiens (human)
extracellular spaceCoagulation factor XHomo sapiens (human)
serine protease inhibitor complexCationic trypsinBos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (17)

Assay IDTitleYearJournalArticle
AID211045In vitro inhibition of human thrombin(FIIa).1999Journal of medicinal chemistry, Dec-30, Volume: 42, Issue:26
Synthesis, characterization, and structure-activity relationships of amidine-substituted (bis)benzylidene-cycloketone olefin isomers as potent and selective factor Xa inhibitors.
AID51652Compound (isomer) was tested in the absence of light for inhibitory activity against Human Coagulation factor X1998Journal of medicinal chemistry, Sep-10, Volume: 41, Issue:19
(Z,Z)-2,7-Bis(4-amidinobenzylidene)cycloheptan-1-one: identification of a highly active inhibitor of blood coagulation factor Xa.
AID51676Inhibitory potency was measured against human coagulation factor X1998Journal of medicinal chemistry, Sep-10, Volume: 41, Issue:19
Discovery of N-[2-[5-[Amino(imino)methyl]-2-hydroxyphenoxy]-3, 5-difluoro-6-[3-(4, 5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]pyridin-4-yl]-N-methylgl y cine (ZK-807834): a potent, selective, and orally active inhibitor of the blood coagulation enzyme fa
AID215209Inhibitory potency was measured against bovine trypsin.1998Journal of medicinal chemistry, Sep-10, Volume: 41, Issue:19
Discovery of N-[2-[5-[Amino(imino)methyl]-2-hydroxyphenoxy]-3, 5-difluoro-6-[3-(4, 5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]pyridin-4-yl]-N-methylgl y cine (ZK-807834): a potent, selective, and orally active inhibitor of the blood coagulation enzyme fa
AID7226In vitro inhibition of bovine trypsin(Trp).1999Journal of medicinal chemistry, Dec-30, Volume: 42, Issue:26
Synthesis, characterization, and structure-activity relationships of amidine-substituted (bis)benzylidene-cycloketone olefin isomers as potent and selective factor Xa inhibitors.
AID211218Inhibitory potency was measured against human thrombin1998Journal of medicinal chemistry, Sep-10, Volume: 41, Issue:19
Discovery of N-[2-[5-[Amino(imino)methyl]-2-hydroxyphenoxy]-3, 5-difluoro-6-[3-(4, 5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]pyridin-4-yl]-N-methylgl y cine (ZK-807834): a potent, selective, and orally active inhibitor of the blood coagulation enzyme fa
AID51657Compound was tested for inhibitory activity against human Coagulation factor X1998Bioorganic & medicinal chemistry letters, Aug-18, Volume: 8, Issue:16
Design, synthesis, and biological activity of novel purine and bicyclic pyrimidine factor Xa inhibitors.
AID51847Binding affinity was evaluated against Coagulation factor X1998Bioorganic & medicinal chemistry letters, Jul-21, Volume: 8, Issue:14
Solid-phase synthesis of N-substituted amidinophenoxy pyridines as factor XA inhibitors.
AID51669Inhibitory activity against human Coagulation factor X2000Bioorganic & medicinal chemistry letters, May-01, Volume: 10, Issue:9
Design, synthesis, and in vitro biological activity of indole-based factor Xa inhibitors.
AID52158In vitro inhibition of human coagulation factor Xa (Xa) in a purified enzyme system.1999Journal of medicinal chemistry, Dec-30, Volume: 42, Issue:26
Synthesis, characterization, and structure-activity relationships of amidine-substituted (bis)benzylidene-cycloketone olefin isomers as potent and selective factor Xa inhibitors.
AID215191Compound was tested for inhibitory activity against bovine trypsin1998Bioorganic & medicinal chemistry letters, Aug-18, Volume: 8, Issue:16
Design, synthesis, and biological activity of novel purine and bicyclic pyrimidine factor Xa inhibitors.
AID211009Compound (isomer) was tested in the absence of light for inhibitory activity against thrombin.1998Journal of medicinal chemistry, Sep-10, Volume: 41, Issue:19
(Z,Z)-2,7-Bis(4-amidinobenzylidene)cycloheptan-1-one: identification of a highly active inhibitor of blood coagulation factor Xa.
AID215060Compound (isomer) was tested in the absence of light for inhibitory activity against trypsin.1998Journal of medicinal chemistry, Sep-10, Volume: 41, Issue:19
(Z,Z)-2,7-Bis(4-amidinobenzylidene)cycloheptan-1-one: identification of a highly active inhibitor of blood coagulation factor Xa.
AID211036Compound was tested for inhibitory activity against human thrombin1998Bioorganic & medicinal chemistry letters, Aug-18, Volume: 8, Issue:16
Design, synthesis, and biological activity of novel purine and bicyclic pyrimidine factor Xa inhibitors.
AID1797608Enzyme Inhibition Assay from Article 10.1107/s0907444999007350: \\Crystallographic analysis of potent and selective factor Xa inhibitors complexed to bovine trypsin.\\1999Acta crystallographica. Section D, Biological crystallography, Aug, Volume: 55, Issue:Pt 8
Crystallographic analysis of potent and selective factor Xa inhibitors complexed to bovine trypsin.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2004Journal of molecular biology, Jan-30, Volume: 335, Issue:5
Understanding protein-ligand interactions: the price of protein flexibility.
AID1811Experimentally measured binding affinity data derived from PDB2004Journal of molecular biology, Jan-30, Volume: 335, Issue:5
Understanding protein-ligand interactions: the price of protein flexibility.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's6 (75.00)18.2507
2000's2 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.97

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.97 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.17 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.97)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]